17-44914095-TG-TGG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The ENST00000591327.2(GFAP):​n.1404dupC variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00101 in 1,548,474 control chromosomes in the GnomAD database, including 12 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0058 ( 7 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 5 hom. )

Consequence

GFAP
ENST00000591327.2 non_coding_transcript_exon

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: -0.246

Publications

0 publications found
Variant links:
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
  • Alexander disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Alexander disease type II
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 17-44914095-T-TG is Benign according to our data. Variant chr17-44914095-T-TG is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 323620.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00576 (869/150764) while in subpopulation AFR AF = 0.0206 (844/40956). AF 95% confidence interval is 0.0195. There are 7 homozygotes in GnomAd4. There are 410 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 869 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GFAPNM_002055.5 linkc.462-8dupC splice_region_variant, intron_variant Intron 1 of 8 ENST00000588735.3 NP_002046.1 P14136-1
GFAPNM_001363846.2 linkc.462-8dupC splice_region_variant, intron_variant Intron 1 of 9 NP_001350775.1
GFAPNM_001242376.3 linkc.462-8dupC splice_region_variant, intron_variant Intron 1 of 6 NP_001229305.1 P14136-2
GFAPNM_001131019.3 linkc.462-8dupC splice_region_variant, intron_variant Intron 1 of 7 NP_001124491.1 P14136-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GFAPENST00000588735.3 linkc.462-8dupC splice_region_variant, intron_variant Intron 1 of 8 1 NM_002055.5 ENSP00000466598.2 P14136-1

Frequencies

GnomAD3 genomes
AF:
0.00573
AC:
864
AN:
150658
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0205
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000991
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00321
Gnomad NFE
AF:
0.0000443
Gnomad OTH
AF:
0.00290
GnomAD2 exomes
AF:
0.00107
AC:
169
AN:
158326
AF XY:
0.000744
show subpopulations
Gnomad AFR exome
AF:
0.0169
Gnomad AMR exome
AF:
0.000645
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000500
AC:
699
AN:
1397710
Hom.:
5
Cov.:
30
AF XY:
0.000444
AC XY:
306
AN XY:
689804
show subpopulations
African (AFR)
AF:
0.0187
AC:
592
AN:
31624
American (AMR)
AF:
0.000781
AC:
28
AN:
35832
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25160
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35958
South Asian (SAS)
AF:
0.0000757
AC:
6
AN:
79274
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49376
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5620
European-Non Finnish (NFE)
AF:
0.00000557
AC:
6
AN:
1076900
Other (OTH)
AF:
0.00116
AC:
67
AN:
57966
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
38
76
114
152
190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00576
AC:
869
AN:
150764
Hom.:
7
Cov.:
32
AF XY:
0.00557
AC XY:
410
AN XY:
73556
show subpopulations
African (AFR)
AF:
0.0206
AC:
844
AN:
40956
American (AMR)
AF:
0.000990
AC:
15
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5096
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4748
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10394
Middle Eastern (MID)
AF:
0.00347
AC:
1
AN:
288
European-Non Finnish (NFE)
AF:
0.0000443
AC:
3
AN:
67670
Other (OTH)
AF:
0.00287
AC:
6
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
41
82
123
164
205
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00269
Hom.:
1
Bravo
AF:
0.00653
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 07, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Alexander disease Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 18, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs572562362; hg19: chr17-42991463; API